These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 2566730

  • 1. Clinical importance of the new H2-antagonists.
    Walt RP.
    Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():97-9. PubMed ID: 2566730
    [Abstract] [Full Text] [Related]

  • 2. Comparison of famotidine with cimetidine and ranitidine.
    Berardi RR, Tankanow RM, Nostrant TT.
    Clin Pharm; 1988 Apr; 7(4):271-84. PubMed ID: 2896559
    [Abstract] [Full Text] [Related]

  • 3. Pharmacology of H2-receptor antagonists: an overview.
    Schunack W.
    J Int Med Res; 1989 Apr; 17 Suppl 1():9A-16A. PubMed ID: 2566544
    [Abstract] [Full Text] [Related]

  • 4. Clinical review of histamine2 receptor antagonists.
    Lipsy RJ, Fennerty B, Fagan TC.
    Arch Intern Med; 1990 Apr; 150(4):745-51. PubMed ID: 1970232
    [Abstract] [Full Text] [Related]

  • 5. [Drugs used in the therapy of peptic ulcer with special reference to H2 receptor blockaders].
    De Natale G, De Natale F, Marino A.
    Clin Ter; 1989 Apr 15; 129(1):3-16. PubMed ID: 2567647
    [Abstract] [Full Text] [Related]

  • 6. Famotidine. The ACG Committee on FDA-Related Matters with primary authorship by G. Friedman. American College of Gastroenterology.
    Am J Gastroenterol; 1987 Jun 15; 82(6):504-6. PubMed ID: 2883885
    [Abstract] [Full Text] [Related]

  • 7. Famotidine. Pharmacodynamic and pharmacokinetic properties and a preliminary review of its therapeutic use in peptic ulcer disease and Zollinger-Ellison syndrome.
    Campoli-Richards DM, Clissold SP.
    Drugs; 1986 Sep 15; 32(3):197-221. PubMed ID: 2875864
    [Abstract] [Full Text] [Related]

  • 8. Famotidine: clinical applications of a new H2-receptor antagonist. May 16, 1986, Carmel, California.
    Am J Med; 1986 Oct 24; 81(4B):1-64. PubMed ID: 2877568
    [No Abstract] [Full Text] [Related]

  • 9. Nocturnal acid suppression with a new H2 receptor antagonist--nizatidine.
    Dammann HG, Gottlieb WR, Walter TA, Dreyer M, Müller P, Simon B, Keohane P.
    Hepatogastroenterology; 1986 Oct 24; 33(5):217-20. PubMed ID: 2879782
    [Abstract] [Full Text] [Related]

  • 10. [Nizatidine].
    Romero M, Franzosi MG.
    Medicina (Firenze); 1989 Oct 24; 9(1):93-6. PubMed ID: 2567957
    [Abstract] [Full Text] [Related]

  • 11. A comparison of nizatidine with the three other histamine receptor antagonists for duodenal ulcer therapy.
    Lima M, Holdcroft C.
    Nurse Pract; 1989 Feb 24; 14(2):41-2. PubMed ID: 2564655
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. New H2-blockers: does more choice help?
    Drug Ther Bull; 1988 Aug 22; 26(17):65-6. PubMed ID: 3138097
    [No Abstract] [Full Text] [Related]

  • 14. Famotidine. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in peptic ulcer disease and other allied diseases.
    Langtry HD, Grant SM, Goa KL.
    Drugs; 1989 Oct 22; 38(4):551-90. PubMed ID: 2573505
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological management of patients with peptic ulcer disease: prospects for the late 1980's.
    Thomson AB, Mahachai V.
    Clin Invest Med; 1987 May 22; 10(3):152-70. PubMed ID: 2887321
    [Abstract] [Full Text] [Related]

  • 16. Peptic ulceration.
    Weir DG.
    Br Med J (Clin Res Ed); 1988 Jan 16; 296(6616):195-200. PubMed ID: 2892567
    [No Abstract] [Full Text] [Related]

  • 17. The effect of an oral morning dose of nizatidine and ranitidine on gastric acid secretion in duodenal ulcer patients.
    Lazzaroni M, Bianchi Porro G.
    Hepatogastroenterology; 1989 Dec 16; 36(6):490-3. PubMed ID: 2575571
    [Abstract] [Full Text] [Related]

  • 18. [Medical therapy of peptic ulcer: problems and prospects].
    Trabucchi E, Foschi D, Belloli P, Montorsi F, Marchetti V, Mariscotti C, Diamantini S.
    Minerva Dietol Gastroenterol; 1989 Dec 16; 35(1):1-6. PubMed ID: 2566959
    [Abstract] [Full Text] [Related]

  • 19. Head-column field-amplified sample stacking in capillary electrophoresis for the determination of cimetidine, famotidine, nizatidine, and ranitidine-HCl in plasma.
    Wu SM, Ho YH, Wu HL, Chen SH, Ko HS.
    Electrophoresis; 2001 Aug 16; 22(13):2717-22. PubMed ID: 11545397
    [Abstract] [Full Text] [Related]

  • 20. [The status of H2-blocker therapy today].
    Rameis H.
    Wien Med Wochenschr; 1992 Aug 16; 142(18):398-405. PubMed ID: 1362029
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.